Taxus Pharmaceuticals (TXSP) Stock Price, News & Analysis

Company Overview

Taxus Pharmaceuticals Holdings, Inc., a specialty retailer, sells dietary supplement products in New York. It offers vitamins, minerals, herbs, supplements, calcium, fibers, proteins, sports nutrition items, and other health and wellness products. The company was formerly known as Little Neck Health Connection, Inc. and changed its name to Taxus Pharmaceuticals Holdings, Inc. in September 2014. Taxus Pharmaceuticals Holdings, Inc. was founded in 2002 and is based in Little Neck, New York.

Key Stats

• Today's Range: $27.00 to $27.00
• 50-Day Range: N/A
• 52-Week Range: $3.16 to $3.16
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $2.20 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TXSP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Taxus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Taxus Pharmaceuticals investors own include Garmin (GRMN), Meta Platforms (META), Pan American Silver (PAAS), WPP (WPP), Argo Group International (ARGO) and NIKE (NKE).

Company Calendar

• Today: 6/17/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Stores & Proprietary Stores
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TXSP
• CIK: 1622676
• Web: N/A
• Phone: 718-631-1522
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 81,500,000
• Free Float: N/A
• Market Cap: $2.20 billion
• Optionable: Not Optionable
• Beta: 0.95